China SXT Pharmaceuticals (SXTC) Other Non-Current Liabilities (2019 - 2026)
China SXT Pharmaceuticals (SXTC) reported Other Non-Current Liabilities of $16,563 for fiscal Q4 2026 (quarter ended Mar 31, 2026), down 69.3% from $53,885 a year earlier.
Powered by 
Analysis
China SXT Pharmaceuticals (SXTC) Other Non-Current Liabilities (2019 - 2026) Analysis & Trends
Dating back to fiscal Q4 2019, China SXT Pharmaceuticals' Other Non-Current Liabilities record includes 15 quarters.
- Other Non-Current Liabilities has a five-year compound annual growth rate of -48.8% (FY2021 to FY2026).
- By fiscal year, Other Non-Current Liabilities came in at $53,885 in FY2025 (-74.8%), $213,571 in FY2024 (+90.8%), $111,951 in FY2023 (-8.8%) and $122,773 in FY2022 (-74.0%).
- Five-year quarterly Other Non-Current Liabilities spans a low of $16,191 in fiscal Q2 2026 and a high of $480,227 in fiscal Q2 2022.
- Year over year, Other Non-Current Liabilities gained in 1 of the last four quarters, with an average decline of 46.6%.
- The high point for year-over-year Other Non-Current Liabilities in five years was fiscal Q2 2022 (growth of 358.2%); the low point was fiscal Q2 2026 (a decline of 92.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | China SXT Pharmaceuticals | 251.61 | -85.95 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 13.77 Mn |
| Sep 30, 2025 | 16,191.00 |
| Mar 31, 2025 | 53,885.00 |
| Sep 30, 2024 | 7.45 Mn |
| Mar 31, 2024 | 213,571.00 |
| Sep 30, 2023 | 146,049.00 |
| Mar 31, 2023 | 111,951.00 |
| Sep 30, 2022 | 109,411.00 |
| Mar 31, 2022 | 122,773.00 |
| Sep 30, 2021 | 480,227.00 |
| Mar 31, 2021 | 472,282.00 |
| Sep 30, 2020 | 104,814.00 |
| Mar 31, 2020 | 113,611.00 |
| Sep 30, 2019 | 73,533.00 |
| Mar 31, 2019 | 78,317.00 |
API Access
China SXT Pharmaceuticals Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=SXTC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "SXTC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=SXTC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();